These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 3555030)
1. Controlled, comparative study of ciprofloxacin versus ampicillin in treatment of bacterial respiratory tract infections. Wollschlager CM; Raoof S; Khan FA; Guarneri JJ; LaBombardi V; Afzal Q Am J Med; 1987 Apr; 82(4A):164-8. PubMed ID: 3555030 [TBL] [Abstract][Full Text] [Related]
2. Ciprofloxacin: an update on clinical experience. Arcieri G; Griffith E; Gruenwaldt G; Heyd A; O'Brien B; Becker N; August R Am J Med; 1987 Apr; 82(4A):381-6. PubMed ID: 3555063 [TBL] [Abstract][Full Text] [Related]
3. Ciprofloxacin versus cinoxacin in therapy of urinary tract infections. A randomized, double-blind trial. Goldstein EJ; Kahn RM; Alpert ML; Ginsberg BP; Greenway FL; Citron DM Am J Med; 1987 Apr; 82(4A):284-7. PubMed ID: 3555049 [TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of ciprofloxacin in the treatment of patients with respiratory tract infections in Japan. Kobayashi H Am J Med; 1987 Apr; 82(4A):169-73. PubMed ID: 3555031 [TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis. Hessen MT; Ingerman MJ; Kaufman DH; Weiner P; Santoro J; Korzeniowski OM; Boscia J; Topiel M; Bush LM; Kaye D Am J Med; 1987 Apr; 82(4A):262-5. PubMed ID: 3555045 [TBL] [Abstract][Full Text] [Related]
6. A comparative randomized double-blind clinical trial of pivampicillin and ampicillin in lower respiratory tract infections. Dewan J; Malik SK; Jindal SK; Sharma PL Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):85-7. PubMed ID: 7037662 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of oral ciprofloxacin in the treatment of respiratory tract infections associated with chronic hepatitis. Esposito S; Galante D; Bianchi W; Gagliardi R Am J Med; 1987 Apr; 82(4A):211-4. PubMed ID: 3555038 [TBL] [Abstract][Full Text] [Related]
8. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria. Preheim LC; Cuevas TA; Roccaforte JS; Mellencamp MA; Bittner MJ Am J Med; 1987 Apr; 82(4A):295-300. PubMed ID: 3555051 [TBL] [Abstract][Full Text] [Related]
9. Treatment of nongonococcal urethritis with ciprofloxacin. Fong IW; Linton W; Simbul M; Thorup R; McLaughlin B; Rahm V; Quinn PA Am J Med; 1987 Apr; 82(4A):311-6. PubMed ID: 3555054 [TBL] [Abstract][Full Text] [Related]
10. Sequential intravenous-oral administration of ciprofloxacin vs ceftazidime in serious bacterial respiratory tract infections. Khan FA; Basir R Chest; 1989 Sep; 96(3):528-37. PubMed ID: 2670465 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of oral ciprofloxacin in the treatment of serious respiratory infections. Fass RJ Am J Med; 1987 Apr; 82(4A):202-7. PubMed ID: 3555037 [TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea. Pichler HE; Diridl G; Stickler K; Wolf D Am J Med; 1987 Apr; 82(4A):329-32. PubMed ID: 3555057 [TBL] [Abstract][Full Text] [Related]
13. Dual individualization of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Nix DE; Sands MF; Peloquin CA; Vari AJ; Cumbo TJ; Vance JW; Fracasso JE; Schentag JJ Am J Med; 1987 Apr; 82(4A):352-6. PubMed ID: 3555060 [TBL] [Abstract][Full Text] [Related]
14. Ampicillin/sulbactam compared with cefotaxime in the treatment of lower respiratory tract infections of bacterial etiology. Jauregui L; Minns P; Hageage G Adv Ther; 1995; 12(1):62-71. PubMed ID: 10150322 [TBL] [Abstract][Full Text] [Related]
15. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006. Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477 [TBL] [Abstract][Full Text] [Related]
16. A comparative study of talampicillin and ampicillin in general practice. Jaffé G; Murphy JE; Robinson OP Practitioner; 1976 Apr; 216(1294):455-60. PubMed ID: 1273032 [TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of ciprofloxacin in lower respiratory tract infections. Pedersen SS Scand J Infect Dis Suppl; 1989; 60():89-97. PubMed ID: 2667111 [TBL] [Abstract][Full Text] [Related]
18. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients. Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729 [TBL] [Abstract][Full Text] [Related]
19. Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections. Pérez-Ruvalcaba JA; Quintero-Pérez NP; Morales-Reyes JJ; Huitrón-Ramírez JA; Rodríguez-Chagollán JJ; Rodríguez-Noriega E Am J Med; 1987 Apr; 82(4A):242-6. PubMed ID: 3555042 [TBL] [Abstract][Full Text] [Related]
20. Brodimoprim: therapeutic efficacy and safety in the treatment of bacterial infections. Braunsteiner AR; Finsinger F J Chemother; 1993 Dec; 5(6):507-11. PubMed ID: 8195846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]